Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30136% above fair value
$289.92+0.42 (+0.15%)
Close on Nov 19, 2026Market cap $41.79BP/E –Yield –
Natera shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Natera's shares outstanding was 143M at Jun 30, 2026. For fiscal 2025 it was 137M, up 9.6% from the year before. Over ten years it grew 18.0% a year on average. The highest annual figure on record is 137M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 137M | +9.6% |
| FY2024 | Dec 31, 2024 | 125M | +8.5% |
| FY2023 | Dec 31, 2023 | 115M | +16.9% |
| FY2022 | Dec 31, 2022 | 98M | +8.7% |
| FY2021 | Dec 31, 2021 | 91M | +11.8% |
| FY2020 | Dec 31, 2020 | 81M | +16.5% |
| FY2019 | Dec 31, 2019 | 70M | +20.2% |
| FY2018 | Dec 31, 2018 | 58M | +7.9% |
| FY2017 | Dec 31, 2017 | 54M | +3.9% |
| FY2016 | Dec 31, 2016 | 52M | +96.8% |
| FY2015 | Dec 31, 2015 | 26M | +445.9% |
| FY2014 | Dec 31, 2014 | 5M | +25.0% |
| FY2013 | Dec 31, 2013 | 4M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 143M | +5.1% |
| Q1 FY2026 | Mar 31, 2026 | 142M | +5.0% |
| Q4 FY2025 | Dec 31, 2025 | 138M | +5.3% |
| Q3 FY2025 | Sep 30, 2025 | 137M | +10.8% |
| Q2 FY2025 | Jun 30, 2025 | 136M | +11.0% |
| Q1 FY2025 | Mar 31, 2025 | 135M | +11.5% |
| Q4 FY2024 | Dec 31, 2024 | 131M | +10.1% |
| Q3 FY2024 | Sep 30, 2024 | 124M | +7.5% |
| Q2 FY2024 | Jun 30, 2024 | 123M | +8.1% |
| Q1 FY2024 | Mar 31, 2024 | 121M | +8.1% |
| Q4 FY2023 | Dec 31, 2023 | 119M | +14.3% |
| Q3 FY2023 | Sep 30, 2023 | 115M | +18.7% |
| Q2 FY2023 | Jun 30, 2023 | 114M | +17.7% |
| Q1 FY2023 | Mar 31, 2023 | 112M | +16.9% |
| Q4 FY2022 | Dec 31, 2022 | 104M | +10.1% |
| Q3 FY2022 | Sep 30, 2022 | 97M | +4.9% |
| Q2 FY2022 | Jun 30, 2022 | 97M | +9.7% |
| Q1 FY2022 | Mar 31, 2022 | 96M | +10.3% |
| Q4 FY2021 | Dec 31, 2021 | 95M | +10.6% |
| Q3 FY2021 | Sep 30, 2021 | 93M | +14.4% |
| Q2 FY2021 | Jun 30, 2021 | 88M | +11.4% |
| Q1 FY2021 | Mar 31, 2021 | 87M | +10.7% |
| Q4 FY2020 | Dec 31, 2020 | 86M | +11.9% |
| Q3 FY2020 | Sep 30, 2020 | 81M | +14.8% |
| Q2 FY2020 | Jun 30, 2020 | 79M | +15.9% |
| Q1 FY2020 | Mar 31, 2020 | 78M | +24.6% |
| Q4 FY2019 | Dec 31, 2019 | 77M | +23.6% |
| Q3 FY2019 | Sep 30, 2019 | 70M | +16.3% |
| Q2 FY2019 | Jun 30, 2019 | 68M | +25.1% |
| Q1 FY2019 | Mar 31, 2019 | 63M | +16.1% |
| Q4 FY2018 | Dec 31, 2018 | 62M | +12.5% |
| Q3 FY2018 | Sep 30, 2018 | 61M | +13.3% |
| Q2 FY2018 | Jun 30, 2018 | 55M | +2.8% |
| Q1 FY2018 | Mar 31, 2018 | 54M | +2.1% |
| Q4 FY2017 | Dec 31, 2017 | 55M | +5.2% |
| Q3 FY2017 | Sep 30, 2017 | 53M | +2.8% |
| Q2 FY2017 | Jun 30, 2017 | 53M | – |
| Q1 FY2017 | Mar 31, 2017 | 53M | – |
| Q4 FY2016 | Dec 31, 2016 | 52M | – |
| Q3 FY2016 | Sep 30, 2016 | 52M | – |
See a number that looks wrong?